Navigation Links
Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
Date:3/3/2008

HOLMDEL, N.J., March 3 /PRNewswire/ -- Sparta Systems, Inc. (Sparta), the maker of TrackWise,(R) and the market leader in enterprise quality and compliance management software, announced today that Bioniche Pharma, a leading developer and manufacturer of sterile injectable pharmaceutical and Medical Device products, deployed TrackWise to handle its critical quality management and compliance activities.

Given the complexity of the pharmaceutical field, companies face strict regulations that require stringent levels of accuracy. Deviations from validated and other processes can affect quality, and as a result, need to be recorded, assessed for product impact and investigated to determine root cause.

After a stringent vendor evaluation process, Bioniche Pharma selected TrackWise to replace its manual systems that manage deviations. TrackWise helps organizations increase efficiency by managing all deviations and other events in a consolidated repository - resulting in faster time-to-closure. Initial deployment of TrackWise will manage deviations, and then a phased rollout will include customer complaints, incidents, CAPA and change controls.

"The utilization of TrackWise is an excellent demonstration of the Continuous Improvement Program at Bioniche Pharma. TrackWise delivers significant benefits over manual systems, and will allow us to electronically record all quality issues in a single integrated system," said Andrew Hall, Director of Quality and Qualified Person at Bioniche Pharma.

"We are very pleased to have Bioniche Pharma join the ranks of the many innovative companies utilizing TrackWise," stated Sahaf Flam, Managing Director of Sparta Systems Europe. "TrackWise offers its customers a 100 percent configurable solution to meet their regulatory and compliance needs, and the solution can be deployed across any number of quality areas without requiring custom code or scripting to implement user requirements."

About Sparta Systems

Sparta Systems, Inc. is the industry leader for global quality and compliance management systems. Its TrackWise product is a web-based enterprise software application used by quality, manufacturing, regulatory affairs, and business professionals to manage quality, compliance issues, and action items across the enterprise. The company has more than 12 years of experience and an extensive customer base in the life sciences and other highly regulated industries. Sparta Systems offers its customers a complete solution for global quality management needs, including the onsite support required throughout the project lifecycle. More information about Sparta Systems and TrackWise can be found at http://www.sparta-systems.com.

About Bioniche Pharma

The Bioniche Pharma Group develops, manufactures and distributes sterile injectable pharmaceuticals in vials, ampoules and pre-filled syringes. The Group has a growing business in the development and manufacturing of pharmaceutical products, with an active pipeline of products at various stages of registration for North American and European markets. In addition, the Group manufactures proprietary products for Bioniche Life Sciences' human and animal health divisions.
http://www.bioniche.com/

PR Contacts: Jon Rabinowitz

Director of Marketing

Sparta Systems, Inc.

Tel: 732-203-0400 x121

jon.rabinowitz@sparta-systems.com


'/>"/>
SOURCE Sparta Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
2. Bioniche Reports Fiscal 2008 Second Quarter
3. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
4. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
5. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
6. Bioniche Reports Fiscal 2008 First Quarter
7. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
8. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
9. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
10. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... CA (PRWEB) , ... January 24, 2017 , ... Learn ... studies, work, athletics or even in relationships. Course offered by Dr. Carol Francis ... necessary due to limited seating and the many hands-on experiences. , Dr. ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... advocacy company, announced today that its annual Solutions Series of webinars will start ... industry thought leaders discussing a number of current health and benefits topics, including ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... Bellus Medical, ... company’s team of medical experts. In his new role Dr. Dobke will provide physician ... , Dr. Dobke is the Head of Plastic Surgery and Associate Professor of Surgery ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions ... new report from the Frank Hawkins Kenan Institute of Private Enterprise ... academics and policy makers identified concrete solutions at the “What’s Next, America?” conference ...
(Date:1/24/2017)... , ... January 24, 2017 , ... The results from ... for everyone and particularly good news for prostate cancer patients: incidents of cancer is ... According to the report the cancer death rate has dropped from its peak of ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... January 24, 2017 www.Financialbuzz.com ... industries in the United States as ... 2016. In addition, Proposition 64, the California Cannabis Legalization Initiative, ... against on November 8, 2016. This outcome means that individuals ... and to grow a certain amount of cannabis for personal ...
(Date:1/24/2017)... , Jan. 24, 2017   QR Pharma ... company developing novel therapies for the treatment of ... the appointment of four world-class key opinion leaders ... appointments join QR Pharma,s previous roster of impressive ... direction to support the development of the breakthrough ...
(Date:1/24/2017)... 2017 Mezzion has filed a suit for ... alleging that Dr. Reddy,s committed fraud relating to Dr. ... Administration (FDA) cGMP practices, and misrepresenting its compliance to ... to Mezzion that it was compliant with FDA regulations, ... suit also states that Dr. Reddy,s misconduct was the ...
Breaking Medicine Technology: